TickerFacts.

Neogen Corp (NEOG): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$408.50M
Year ended 2026-05-31
+0.2%
3-year compound annual growth
+13.7%
5-year compound annual growth
$463.90M2010-05-31: $72.97M2011-05-31: $87.79M2012-05-31: $92.42M2013-05-31: $109.49M2014-05-31: $122.60M2015-05-31: $139.69M2016-05-31: $153.06M2017-05-31: $168.92M2018-05-31: $186.27M2019-05-31: $191.92M2020-05-31: $196.28M2021-05-31: $215.06M2022-05-31: $243.01M2023-05-31: $405.95M2024-05-31: $463.90M2025-05-31: $421.40M2026-05-31: $408.50M$408.50M
2010-05-31 Gross Profit (USD) 2026-05-31
Period endedGross ProfitChange YoYSource filing
2026-05-31$408.50M-3.1%2026-07-30, From 2025-06-01
2025-05-31$421.40M-9.2%2026-07-30, From 2024-06-01
2024-05-31$463.90M+14.3%2026-07-30, From 2023-06-01
2023-05-31$405.95M+67.1%2025-07-30, From 2022-06-01
2022-05-31$243.01M+13.0%2024-07-30, From 2021-06-01
2021-05-31$215.06M+9.6%2023-08-15, From 2020-06-01
2020-05-31$196.28M+2.3%2022-07-27, From 2019-06-01
2019-05-31$191.92M+3.0%2021-07-30, From 2018-06-01
2018-05-31$186.27M+10.3%2020-07-30, From 2017-06-01
2017-05-31$168.92Mn/c2019-07-30, From 2016-06-01
2016-05-31$153.06M+9.6%2018-07-27, From 2015-06-01
2015-05-31$139.69M+13.9%2017-07-28, From 2014-06-01
2014-05-31$122.60M+12.0%2016-07-29, From 2013-06-01
2013-05-31$109.49M+18.5%2015-07-30, From 2012-06-01
2012-05-31$92.42M+5.3%2014-07-30, From 2011-06-01
2011-05-31$87.79M+20.3%2013-07-30, From 2010-06-01
2010-05-31$72.97Mn/a2012-07-30, From 2009-06-01

Gross Profit at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Neogen Corp (NEOG)2026-05-31$408.50M-3.1%
Myriad Genetics Inc (MYGN)2025-12-31$576.60M-1.5%
Lantheus Holdings, Inc. (LNTH)2025-12-31$941.95M-4.7%
Idexx Laboratories Inc (IDXX)2025-12-31$2.66B+11.8%
Alpha Teknova, Inc. (TKNO)2025-12-31$13.44M+85.9%
Immucell Corp (ICCC)2025-12-31$11.45M+44.1%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.92M+8.0%
Anbio Biotechnology (NNNN)2025-12-31$7.54M+28.2%
Biomerica Inc (BMRA)2026-05-31$362.0K-27.3%

Compare NEOG, MYGN, LNTH, IDXX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗